Statement from EPWG on Access to Medicines & Poverty Related Diseases – “We are delighted to welcome Nessa Childers MEP as the new Chair of the working group”
“In our work, we are guided by the aspiration to achieve universal health coverage and access to affordable, safe and quality medicines and vaccines for all, in line with the 2030 Agenda for Sustainable Development, and SDG 3 in particular. Our working group wants to see the EU making a significant and positive difference towards that goal.”
“Many thanks to Glenis Willmott MEP who did an amazing job in Chairing the group for two years!
The Working Group remains dedicated ensure the EU is acting as a champion to support better innovation, access to medicines and healthcare and to combat poverty-related and neglected diseases. New challenges ahead, keep posted”.
The European Union has a major impact on access to medicines for developing countries, through its policies, legislation and bilateral and regional trade agreements. It is vital that the EU adopts appropriate measures that improve access to existing medical tools (medicines, diagnostics, vaccines) and that stimulate the research and development (R&D) of urgently-needed better tools for people in developing countries, notably for poverty-related diseases such as HIV/AIDS, tuberculosis and malaria. The Working Group operates as a Bureau of MEPs, with one Chair and four Co-Chairs, and a Secretariat, formed by Médecins Sans Frontières’ Campaign for Access to Essential Medicines and Global Health Advocates. The Working Group is open to MEPs, academics, representatives from the European Commission, international organisations and civil society.